Impact of S-1 adjuvant chemotherapy longer than 6 months on survival in patients with resected pancreatic cancer: a nationwide survey by the Japan Pancreas Society based on real-world data.

MLA

Tomimaru, Yoshito, et al. “Impact of S-1 Adjuvant Chemotherapy Longer than 6 Months on Survival in Patients with Resected Pancreatic Cancer: A Nationwide Survey by the Japan Pancreas Society Based on Real-World Data.” Cancer, vol. 129, no. 5, Mar. 2023, pp. 728–39. EBSCOhost, https://doi.org/10.1002/cncr.34580.

APA

Tomimaru, Y., Eguchi, H., Inoue, Y., Nagakawa, Y., Ohba, A., Takami, H., Unno, M., Yamamoto, T., Kawakatsu, S., Hayashi, T., Higuchi, R., Kitagawa, H., Hattori, S., Fujii, T., Hirooka, Y., Igarashi, H., Kitano, M., Kuroki, T., Masamune, A., … Takeyama, Y. (2023). Impact of S-1 adjuvant chemotherapy longer than 6 months on survival in patients with resected pancreatic cancer: a nationwide survey by the Japan Pancreas Society based on real-world data. Cancer, 129(5), 728–739. https://doi.org/10.1002/cncr.34580

Chicago

Tomimaru, Yoshito, Hidetoshi Eguchi, Yosuke Inoue, Yuichi Nagakawa, Akihiro Ohba, Hideki Takami, Michiaki Unno, et al. 2023. “Impact of S-1 Adjuvant Chemotherapy Longer than 6 Months on Survival in Patients with Resected Pancreatic Cancer: A Nationwide Survey by the Japan Pancreas Society Based on Real-World Data.” Cancer 129 (5): 728–39. doi:10.1002/cncr.34580.